UltraSight has collaborated with the Mayo Clinic to advance cardiac care using AI in point-of-care ultrasound (PoCUS).

The partnership aims to develop algorithms for the analysis and interpretation of cardiac ultrasound images, as well as create a comprehensive solution and decision support system.

This will enable healthcare providers to make more informed diagnoses and treatment decisions with the help of PoCUS devices.

UltraSight CEO Davidi Vortman said: “UltraSight Real-time Guidance software harnesses the power of AI to allow more medical practitioners to capture images with confidence.

“However, obtaining diagnostic quality cardiac images at the patient point of care is only the first step needed to increase patient access to quality care. We firmly believe that point-of-care ultrasound, when enhanced by the capabilities of AI, holds the potential to optimise patient care.

“Through this collaboration, we plan to enhance our solution to detect and manage cardiac conditions in a more scalable and cost-effective way, ultimately helping more patients receive timely treatment.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Mayo Clinic has also invested in UltraSight and now holds a financial interest in the technology being developed.

It has stated that any revenue generated from this venture will be reinvested into its non-profit mission, which focuses on patient care, education, and research.

Mayo Clinic Platform president John Halamka said: “We know that over the next decade, training programs around the world will not graduate enough specialists and technologists to meet the demands of an ageing population.

“The best option in our toolkit is to embrace AI in a way that democratizes access to knowledge. Mayo Clinic and UltraSight will work together to enable a wider spectrum of caregivers to obtain cardiac ultrasound data and understand the results, serving many more patients globally.”

In April 2024, Exact Sciences and Mayo Clinic teamed up to provide advanced cancer testing to patients, including the OncoExTra and Riskguard tests.